BACKGROUND: The Family Investigation of Nephropathy and Diabetes (FIND) is a multicenter study designed to identify genetic determinants of diabetic nephropathy. It is conducted in eight U.S. clinical centers and a coordinating center, and with four ethnic groups (European Americans, African Americans, Mexican Americans, and American Indians). Two strategies are used to localize susceptibility genes: a family-based linkage study and a case-control study using mapping by admixture linkage disequilibrium (MALD). METHODS: In the family-based study, probands with diabetic nephropathy are recruited with their parents and selected siblings. Linkage analyses will be conducted to identify chromosomal regions containing genes that influence the development of diabetic nephropathy or related quantitative traits such as serum creatinine concentration, urinary albumin excretion, and plasma glucose concentrations. Regions showing evidence of linkage will be examined further with both genetic linkage and association studies to identify genes that influence diabetic nephropathy or related traits. Two types of MALD studies are being done. One is a case-control study of unrelated individuals of Mexican American heritage in which both cases and controls have diabetes, but only the case has nephropathy. The other is a case-control study of African American patients with nephropathy (cases) and their spouses (controls) unaffected by diabetes and nephropathy; offspring are genotyped when available to provide haplotype data. CONCLUSIONS: Identification of genes that influence susceptibility to diabetic nephropathy will lead to a better understanding of how nephropathy develops. This should eventually lead to improved treatment and prevention.
BACKGROUND: The Family Investigation of Nephropathy and Diabetes (FIND) is a multicenter study designed to identify genetic determinants of diabetic nephropathy. It is conducted in eight U.S. clinical centers and a coordinating center, and with four ethnic groups (European Americans, African Americans, Mexican Americans, and American Indians). Two strategies are used to localize susceptibility genes: a family-based linkage study and a case-control study using mapping by admixture linkage disequilibrium (MALD). METHODS: In the family-based study, probands with diabetic nephropathy are recruited with their parents and selected siblings. Linkage analyses will be conducted to identify chromosomal regions containing genes that influence the development of diabetic nephropathy or related quantitative traits such as serum creatinine concentration, urinary albumin excretion, and plasma glucose concentrations. Regions showing evidence of linkage will be examined further with both genetic linkage and association studies to identify genes that influence diabetic nephropathy or related traits. Two types of MALD studies are being done. One is a case-control study of unrelated individuals of Mexican American heritage in which both cases and controls have diabetes, but only the case has nephropathy. The other is a case-control study of African American patients with nephropathy (cases) and their spouses (controls) unaffected by diabetes and nephropathy; offspring are genotyped when available to provide haplotype data. CONCLUSIONS: Identification of genes that influence susceptibility to diabetic nephropathy will lead to a better understanding of how nephropathy develops. This should eventually lead to improved treatment and prevention.
Authors: Ursula M Schick; Deepti Jain; Chani J Hodonsky; Jean V Morrison; James P Davis; Lisa Brown; Tamar Sofer; Matthew P Conomos; Claudia Schurmann; Caitlin P McHugh; Sarah C Nelson; Swarooparani Vadlamudi; Adrienne Stilp; Anna Plantinga; Leslie Baier; Stephanie A Bien; Stephanie M Gogarten; Cecelia A Laurie; Kent D Taylor; Yongmei Liu; Paul L Auer; Nora Franceschini; Adam Szpiro; Ken Rice; Kathleen F Kerr; Jerome I Rotter; Robert L Hanson; George Papanicolaou; Stephen S Rich; Ruth J F Loos; Brian L Browning; Sharon R Browning; Bruce S Weir; Cathy C Laurie; Karen L Mohlke; Kari E North; Timothy A Thornton; Alex P Reiner Journal: Am J Hum Genet Date: 2016-01-21 Impact factor: 11.025
Authors: Joanne M Lind; Holli B Hutcheson-Dilks; Scott M Williams; Jason H Moore; Myron Essex; Eduardo Ruiz-Pesini; Douglas C Wallace; Sarah A Tishkoff; Stephen J O'Brien; Michael W Smith Journal: Hum Genet Date: 2006-09-28 Impact factor: 4.132
Authors: Chao Tian; David A Hinds; Russell Shigeta; Sharon G Adler; Annette Lee; Madeleine V Pahl; Gabriel Silva; John W Belmont; Robert L Hanson; William C Knowler; Peter K Gregersen; Dennis G Ballinger; Michael F Seldin Journal: Am J Hum Genet Date: 2007-06 Impact factor: 11.025
Authors: Sulgi Kim; Hanna E Abboud; Madeleine V Pahl; John Tayek; Susan Snyder; James Tamkin; Harry Alcorn; Eli Ipp; Cynthia C Nast; Robert C Elston; Sudha K Iyengar; Sharon G Adler Journal: Clin J Am Soc Nephrol Date: 2010-03-18 Impact factor: 8.237
Authors: Barry I Freedman; Pamela J Hicks; Meredith A Bostrom; Mary E Comeau; Jasmin Divers; Anthony J Bleyer; Jeffrey B Kopp; Cheryl A Winkler; George W Nelson; Carl D Langefeld; Donald W Bowden Journal: Nephrol Dial Transplant Date: 2009-06-30 Impact factor: 5.992
Authors: Kelli M Sas; Pradeep Kayampilly; Jaeman Byun; Viji Nair; Lucy M Hinder; Junguk Hur; Hongyu Zhang; Chengmao Lin; Nathan R Qi; George Michailidis; Per-Henrik Groop; Robert G Nelson; Manjula Darshi; Kumar Sharma; Jeffrey R Schelling; John R Sedor; Rodica Pop-Busui; Joel M Weinberg; Scott A Soleimanpour; Steven F Abcouwer; Thomas W Gardner; Charles F Burant; Eva L Feldman; Matthias Kretzler; Frank C Brosius; Subramaniam Pennathur Journal: JCI Insight Date: 2016-09-22
Authors: Brad P Dieter; Sterling M McPherson; Maryam Afkarian; Ian H de Boer; Rajnish Mehrotra; Robert Short; Celestina Barbosa-Leiker; Radica Z Alicic; Rick L Meek; Katherine R Tuttle Journal: J Diabetes Complications Date: 2016-07-27 Impact factor: 2.852
Authors: Sapna Gangaputra; James F Lovato; Larry Hubbard; Matthew D Davis; Barbara A Esser; Walter T Ambrosius; Emily Y Chew; Craig Greven; Letitia H Perdue; Wai T Wong; Audree Condren; Charles P Wilkinson; Elvira Agrón; Sharon Adler; Ronald P Danis Journal: Retina Date: 2013 Jul-Aug Impact factor: 4.256